Louisiana State Employees Retirement System grew its position in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 0.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 21,300 shares of the scientific and technical instruments company’s stock after buying an additional 100 shares during the period. Louisiana State Employees Retirement System’s holdings in Itron were worth $2,804,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Itron by 129.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock worth $76,713,000 after acquiring an additional 413,487 shares in the last quarter. Amundi increased its holdings in Itron by 18.4% in the 1st quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock worth $97,313,000 after acquiring an additional 144,361 shares in the last quarter. MetLife Investment Management LLC increased its holdings in Itron by 347.2% in the 1st quarter. MetLife Investment Management LLC now owns 121,043 shares of the scientific and technical instruments company’s stock worth $12,680,000 after acquiring an additional 93,977 shares in the last quarter. Trexquant Investment LP increased its holdings in Itron by 122.5% in the 1st quarter. Trexquant Investment LP now owns 168,535 shares of the scientific and technical instruments company’s stock worth $17,656,000 after acquiring an additional 92,773 shares in the last quarter. Finally, Palisades Investment Partners LLC purchased a new stake in Itron in the 2nd quarter worth $9,683,000. 96.19% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Itron news, SVP Donald L. Reeves III sold 547 shares of the company’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $68,544.57. Following the transaction, the senior vice president owned 19,604 shares of the company’s stock, valued at $2,456,577.24. This represents a 2.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Justin K. Patrick sold 388 shares of the company’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $48,620.28. Following the completion of the transaction, the senior vice president directly owned 20,761 shares in the company, valued at $2,601,560.91. The trade was a 1.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,037 shares of company stock valued at $380,566 over the last three months. Company insiders own 1.45% of the company’s stock.
Itron Trading Down 0.7%
Itron (NASDAQ:ITRI – Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to analysts’ expectations of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The company’s revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, equities analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.
Wall Street Analyst Weigh In
ITRI has been the subject of several recent analyst reports. Johnson Rice lowered shares of Itron from a “buy” rating to an “accumulate” rating in a report on Friday, August 1st. JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Stephens reaffirmed an “equal weight” rating and set a $130.00 target price on shares of Itron in a report on Tuesday. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Finally, TD Cowen upped their target price on shares of Itron from $139.00 to $145.00 and gave the stock a “buy” rating in a report on Friday, June 20th. Ten research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Itron presently has an average rating of “Moderate Buy” and an average target price of $137.10.
Itron Profile
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also
- Five stocks we like better than Itron
- Why Are These Companies Considered Blue Chips?
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- What is diluted earnings per share (Diluted EPS)?
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- Bank Stocks – Best Bank Stocks to Invest In
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI – Free Report).
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.